RE: Nice30 Jun 2026 08:07
· EpiSwitch Orion has been introduced into several research centres of excellence, and we are now in commercial discussions with three large pharma companies. In parallel, our Episwitch ME/CFS data has attracted significant interest from both industry and academia and we are seeking to secure non-dilutive/grant funding for this initiative by the end of the calendar year.